Screener

Eligibility screening

Fibromyalgia Response With Esreboxetine Evaluated Using a Randomized Withdrawal Research Design

Sponsored by Axsome Therapeutics, Inc.Study detailsClinicalTrials.gov

16 US sites in AR, CA, CT, FL +9

Before we begin

Who are you filling this out for?

Your answer affects how the questions are phrased.